Medicament for treatment of diabetic foot infections
AssigneeDebiopharm International S.A.
InventorsGrégoire Vuagniaux, Linda Kadi, Frederick Wittke
Life of this patent
Estimating the term…
Abstract
The present invention provides means and methods for treating diabetic foot infections. In particular, drug compounds are provided that combine a high therapeutic activity against Staphylococcus Spp. bacteria with a high degree of bone penetration and vasodilatory effects. This unique combination of properties allows to accomplish high local concentrations of the drug at the site of infection even in diabetic foot patients typically having poor blood perfusion at the site of infection.
Claims20
A method of treating diabetic foot-associated bacterial infections or other bacterial infections of the foot associated with peripheral ischemia in a patient, comprising administering to the patient an effective amount of a compound, wherein the compound is {6-[(1E)-3-{methyl[(3-methyl-1-benzofuran-2-yl)methyl]amino}-3-oxoprop-1-en-1-yl]-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl}methyl dihydrogen phosphate or a pharmaceutically acceptable salt or metabolite or pharmaceutically acceptable salt of a metabolite thereof.
Dependencies are inferred from the claim text.